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Abstract
Background: Traumatic Brain Injury (TBI) is a major cause of death and disability. It has been postulated that brain
metabolic status, intracranial pressure (ICP) and cerebral perfusion pressure (CPP) are related to patients’ outcome.
The aim of this study was to investigate the relationship between CPP, ICP and microdialysis parameters and
clinical outcome in TBIs.
Results: Thirty four individuals with severe brain injury hospitalized in an intensive care unit participated in this
study. Microdialysis data were collected, along with ICP and CPP values. Glasgow Outcome Scale (GOS) was used
to evaluate patient outcome at 6 months after injury. Fifteen patients with a CPP greater than 75 mmHg, L/P ratio
lower than 37 and Glycerol concentration lower than 72 mmol/l had an excellent outcome (GOS 4 or 5), as
opposed to the remaining 19 patients. No patient with a favorable outcome had a CPP lower than 75 mmHg or
Glycerol concentration and L/P ratio greater than 72 mmol/l and 37 respectively. Data regarding L/P ratio and
Glycerol concentration were statistically significant at p = 0.05 when patients with favorable and unfavorable
outcome were compared. In a logistic regression model adjusted for age, sex and Glasgow Coma Scale on
admission, a CPP greater than 75 mmHg was marginally statistically significantly related to outcome at 6 months
after injury.
Conclusions: Patients with favorable outcome had certain common features in terms of microdialysis parameters
and CPP values. An individualized approach regarding CPP levels and cut -off points for Glycerol concentration and
L/P ratio are proposed.
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Background
Traumatic Brain Injury (TBI) is a major cause of death
and disability [1]. Beyond the primary injury, the sec-
ondary insults account for an unfavorable outcome [2].
It is now feasible to monitor a n dr e c o r dp h y s i o l o g i c a l
variables with computerized multimodality monitoring
systems in the neurointensive care unit patients. Moni-
toring assists the physician to implement the appropri-
ate therapy and gives information about the expected
outcome [3,4]. It has been shown that poor outcome is
related to high Intracranial Pressure (ICP), and low
Cerebral Perfusion Pressure (CPP) [5-7]. Besides that,
brain metabolic status, as it is expressed via glucose, gly-
cerol and lactate-pyruvate (L/P) ratio has also been cor-
related to clinical outcome in various studies. High
values of L/P ratio, Glycerol concentration and PbtO2,
as well as low levels of Glucose have been related to
poor outcome. However, data regarding certain cut-off
points for the latter parameters are insufficient. Only
broad value ranges for metabolic parameters are cur-
rently in use. The clinical use of CPP is based on theo-
retical suggestions that maintaining optimal cerebral
blood flow is necessary to meet the metabolic needs of
the injured brain [6]. The goal is to preserve the
ischemic penubra and avoid exacerbation of secondary
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old of CPP value is recommended [8], while there is a
controversy regarding the upper limit of CPP values [7].
It has been postulated that high values of CPP could be
harmful, given that in many brain injuries brain auto-
regulation is severely damaged. However, raised CPP
values could be beneficial to many patients, even at rela-
tively high ICP levels [9]. The aim of this paper was to
investigate the relation of CPP values and clinical out-
come in patients with severe brain injuries as well as to
assess the effectiveness of multimodal brain monitoring
in relation to patients outcome.
Methods
Thirty - four patients (29 men and 5 women) participated
in the study. They had suffered a traumatic brain injury
a n dh o s p i t a l i z a t i o ni na ni n t ensive care unit was neces-
sary (Glasgow Coma Scale ≤ 8). All patients received con-
servative treatment. Informed consent was obtained from
the families of the patients. All patients were intubated,
sedated and occasionally paralyzed. If an emergency
operation was not required, cranial bolts for measure-
ment of PbtO2, ICP and a brain MicroDialysis (MD)
catheters were placed. Τhe three catheters were inserted
into the brain through a triple lumen introducer kit
(Integra, CMA 70 microdialysis bolt catheter) in the right
frontal lobe, in the case of a diffuse damage, or in the
ipsilateral frontal lobe in the case of a regional damage. A
networked computerized multimodality monitoring sys-
tem was used. Microdialysis data were collected every 2
hours and ICP and CPP were studied. Brain Glucose
(Glu), Glycerol (Gly), Pyruvate, Lactate concentrations
and PbtO2 were monitored. All patients were treated
according to modern neurointensive care principles. The
goal was to maintain a level of ICP < 20 mmHg, an
acceptable PbtO2 ~ 20 mm, a Lactate/Pyruvate (L/P)
ratio around 20-25, and definitely below 40. CPP values
were appropriately adjusted, among other neuroprotec-
tive interventions, in order to achieve the aforementioned
objective. The brain monitoring commenced within the
first 24 hours of brain injury and continued until cathe-
ters were removed due to normalization of the monitored
parameters without any neuroprotective intervention for
24 hours. For homogeneity reasons, in the case of pro-
longed monitoring, data from the first 10 days of hospita-
lization were evaluated. Glasgow Outcome Scale was
used to evaluate patient outcome at 6 months after the
injury. Ethical approval was given with the 158-22711
decision of the local ethical committee ("Koutlimpaneio
& Triantafyllio Hospital” Scientific Committee).
Statistics
The Mann-Whitney U-test was used to compare median
values of variables that were not normally distributed
(Normality control test: Shapiro-Wilk). GOS variable
was dichotomized (binary distribution) according to
favorable and unfavorable outcomes. Values greater than
3 (> 3) were considered as favorable outcome, while
values ≤3 as an unfavorable one.
Mean CPP values were dichotomized at the level of 75
mmHg. The x
2 test was used for comparisons of out-
come rates, and Fisher’s exact probability test was used,
when the number of observations in a 2 × 2 contingency
table was small enough. A logistic regression model was
used for outcome prognosis. SPSS 17.0 was used for
statistics.
Results
Demographic characteristics of the sample, evaluation
data on admission and outcome are shown in Table 1.
Twenty nine patients were men and 5 women. Mean
age was 43.6 yrs ± 18.70. Median GCS value on admis-
sion was 7. 15 patients had a favorable prognosis at 6
months, 19 patients had an unfavorable one, whereas 14
patients of the latter group died (Mortality rate 41.2%)
(Table 1). Differences in microdialysis markers and
CPP/ICP values between the two groups of favorable
and unfavorable outcome are shown in Table 2. Mean
values of PbtO2, CPP, ICP and glucose concentration
were higher in the group of favorable outcome, while L/
P ratio and Glycerol concentration was lower. A statisti-
cally significant difference was observed when compar-
ing the distributions of L/P ratio and glycerol in the two
groups.
The study of L/P and Glucerol concentration distribu-
tions revealed that no patient with favorable prognosis
had either an L/P ratio or a Glycerol concentration
greater than 37 and 72 mmol/l respectively. Regarding
CPP distribution, no patient with a favorable prognosis
had a CPP value lower than 75. Six patients with an
unfavorable outcome had an L/P value and a Glycerol
concentration lower than 37 and 72 mmol/l respectively.
Five patients with an unfavorable outcome had a CPP
value lower than 75 mmHg (Table 3). If the aforemen-
tioned critical values were regarded as cut-off points,
meaningful statistical results were produced for L/P,
CPP and glycerol values. A statistically significant differ-
ence was established between the favorable and unfavor-
able prognosis groups regarding L/P and Glycerol, while
a marginal significance was found for CPP. It is noted,
that all 15 patients with a favorable outcome had L/P
ratio < 37, CPP ≥ 75 mmHg and glycerol < 72 mmol/l.
ROCs for Glycerol, L/P and CPP are presented in Figure
1. Regarding the other parameters, 3 patients with favor-
able outcome had a Glucose concentration greater than
2.75, 3 patients had a PbtO2 greater then 37, while 1
patient had an ICP value greater than 60 mmHg (data
not shown). The mean value of PbtO2 was slightly
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broader standard deviation. However, no statistically sig-
nificant difference was observed between the two groups
(favorable outcome group: 32.33 ± 14.93, unfavorable
outcome group: 29.51 ± 5.91, F = 1.2, t = -0.17,p =
0.864). Variables that were statistically significantly
related to outcome in the univariate analysis were
included in a logistic regression model. After adjusting
for age, sex and GCS on admission, the odds for the
patients with a CPP greater than 75 mmHg were 11.1
higher for favorable outcome at 6 months after the
injury (p = 0.052-Table 4).
Discussion
According to the findings of the present study, certain
cut-off values in microdialysis parameters are helpful to
determine patients’ outcome. Favorable outcome was
also related to CPP values beyond the consensus range
of 60-70 mmHg.
There has been a controversy about CPP upper limits
in patients with severe head injuries [6,7,10,11]. A lower
CPP goal of 60 mmHg has been endorsed by the Ameri-
can Association of Neurological Surgeons and recently
the Brain Trauma Foundation suggested a general
threshold in the realm of 50-70 mmHg [8]. In this
Table 1 Demographic characteristics of the sample, evaluation on admission and outcome
Mean Value/Median (25th-75th) SD N
Patients age 43,6 18,7 34
Sex (men/women) 29/5
GCS score on admission 7 (6-8)
Favorable outcome at 6 months 15 (44.1%)
Unfavorable outcome at 6 months 19 (55.9%)
Mortality rate 14/34 (41.2%)
Table 2 MD values in favorable and unfavorable outcome groups
L/P GLU GLY ICP CPP PbtO2
Unfavorable outcome N 19 19 19 19 19 19
Mean 31.86 1.12 80.68 20.42 84.58 29.51
Median 34.17 1.00 66.10 16.00 84.00 28.30
SD 8.33 0.61 50.46 14.65 8.87 5.91
Min 13 0.11 25.92 6 70 20.45
Max 46 2.75 216.80 60 98 37.70
Percentiles 5 13.20 0.11 25.92 6.00 70.00 20.45
25 25.39 0.78 51.29 12.00 77.00 24.01
50 34.17 1.00 66.10 16.00 84.00 28.30
75 38.18 1.36 103.98 23.00 94.00 34.84
95 46.35 2.75 216.80 60.00 98.00 37.70
Favorable outcome N 15 15 15 15 15 15
Mean 24.10 1.57 38.64 27.20 78.53 32.33
Median 24.03 0.91 33.18 20.00 82.00 29.03
SD 6.88 1.46 13.19 18.21 23.05 14.93
Min 13 0.41 24.86 13 75 17.56
Max 37 5.07 71.48 82 103 80.29
Percentiles 5 12.86 0.41 24.86 13.00 5.00 17.56
25 18.13 0.62 30.31 17.00 72.00 22.58
50 24.03 0.91 33.18 20.00 82.00 29.03
75 30.18 2.71 42.10 29.00 89.00 36.47
95 36.53 5.07 71.48 82.00 103.00 80.29
p 0.007* 0.811** 0.000** 0.071** 0.248* 0.455*
*Mann-Whitney-U test
**T-test
Paraforou et al. BMC Research Notes 2011, 4:540
http://www.biomedcentral.com/1756-0500/4/540
Page 3 of 6study, CPP regulation was guided by brain biochemistry
and emphasis was placed on clinical outcome, provided
that L/P ratio and PbtO2 remained at an acceptable
level. The sum of patients with a favorable prognosis
raised with an increased CPP beyond 70 mmHg. The 75
mmHg finally turned out to be the critical value.
Patients who survived and exhibited CPP values over 75
mmHg exhibited an excellent outcome as well. The
explanation possibly lies in PbtO2. Stocchetti et al. had
found that cerebral perfusion pressure augmentation sig-
nificantly increased levels of brain tissue oxygen and sig-
nificantly reduced the regional oxygen extraction
fraction. Patients with baseline PbtO2 values at low
levels had demonstrated a greater increase in PbO2 in
response to CPP augmentation [12]. Values greater than
60 mmHg were also related to a more favorable PbtO2
Table 3 CPP, L/P ratio and Glycerol concentration in
patients with favorable and unfavorable outcome
Parameters Outcome
Unfavorable Favorable Total
CPP < 75 mmHg 5 0 5
CPP ≥ 75 mmHg 14 15 29
Total 19 15 34
Fischer’s test, p = 0.053
L/P > 37 6 0 6
L/P ≤ 37 13 15 28
Total 19 15 34
Fischer’s test, p = 0.024
Glycerol > 72 mmol/l 6 0 6
Glycerol ≤ 72 mmol/l 14 15 28
Total 19 15 34
Fischer’s test, p = 0.024
Figure 1 ROCs for CPP, Glycerol and L/P values.
Table 4 Logistic regression model for outcome prognosis
adjusted for age and gender
B Sig. Odds Ratio 95% C.I.for Exp(B)
Lower Upper
CPP ≥ 75 mmHg -2.407 0.052 11.1 0.970 125.000
Glycerol > 72 μg/lt 0.247 0.867 1.280 0.071 23.192
Lp > 37 -2.583 0.202 0.076 0.001 3.998
Age 0.001 0.977 0.999 0.956 1.044
GCS 0.149 0.565 1.161 0.699 1.929
Gender (men = 1) -1.995 0.117 0.136 0.011 1.653
Constant 2.029 0.428 7.605
Dependent variable: Outcome.
Coding: Favorable outcome = 1, Unfavorable = 2, CPP ≥ 75 = 2, CPP < 75 = 1
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been reported by Johnston et al. [14] and other
researchers. Rosner and colleagues have studied the
maintenance of a CPP greater than 70 mmHg in
patients with severe TBI. Their results were excellent,
with an overall mortality rate of 21%. Fifty-four percent
of survivors had a good recovery or moderate disability
[15]. In their recent study, Nelson et al. demonstrated
that patients with traumatic brain injury and a CPP in
the realm of 70 mmHg exhibited better prognosis,
although no significant relation was found between out-
come and MD and MD values were poorly related to
CPP [16].
Regarding L/P ratio and Glycerol, existing data also
support our findings. Hutchinson et al. measured an L/P
value of 26.38 ± 8.1 in patients with a traumatic brain
injury, without signs of ischemia using PET (Positron
Emission Tomography), with a normal Oxygen Extrac-
tion Fraction (OEF was approximately 0.4) [17]. In a
study including 21 patients who underwent surgery for
a hematoma caused by spontaneous intracerebral
hemorrhage, it was found that the zone surrounding the
evacuated hematoma area exhibited a biochemical beha-
vior similar to that of the zone surrounding the brain
contusion, with an increase in the value of the lactic-
pyruvate ratio of about 35 and an increase in glycerol
concentration [11]. That fact can be helpful in making a
decision, whether the injury should be treated surgically
or not.
Regarding Glycerol concentration, our data are in
accordance with those of Peerderman et al., which mea-
sured glycerol levels in 15 patients with traumatic brain
injury. Patients with an unfavorable prognosis had
higher glycerol levels during the first 24 h of hospitaliza-
tion. They also noticed that no patient with favorable
prognosis had a glycerol concentration greater than 150
μmol/L, while 6 out of 10 patients with an unfavorable
prognosis had one. [18]. Clausen at al also observed sig-
nificantly increased glycerol concentrations when PbtO2
was lower than 10 mm Hg or when cerebral perfusion
pressure was lower than 70 mm Hg in TBI patients [19].
The low GCS on admission could account for the
relatively high mortality in the present study. Depending
on severity, TBI mortality rates within a 6 month period
after the injury, ranged from 3% to 35% [20]. The rela-
tionship between TBI severity at onset and mortality is
well documented [21,22]. It is noticed, however, that
our data refer to adults below 65 years old, suffering
from severe TBIs, who were administered conservative
treatment only. A model including as many clinical and
laboratory parameters as possible and a large number of
patients with specific and homogenous brain damage
features is necessary for definite conclusions to be
drawn.
Conclusion
The findings of this study support the maintenance of
high CPP levels guided by the metabolic status of the
brain tissue and suggest certain cut-off values for micro-
dialysis parameters. The findings support the latest BTF
guidelines, which suggest a more individualized approach
in CPP regulation. However, optimal CPP values may
vary from patient to patient and over time, as the physio-
logical environment of the injured brain changes. Neu-
rointensivists should not be discouraged to maintain high
CPP levels, if the brain metabolic state allows so. We sug-
gest a broader monitoring including PbtO2, microdialy-
sis, and local cerebral blood flow measure. Interventions
should be guided by each patient’s brain metabolic status,
aiming for the best possible outcome.
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